Additionally, activated Treg cells can produce cytokines such as IL-35 and IL-27, which drive the expression of PD1 and TIM3, thereby creating a profoundly suppressive tumor immune microenvironment [38–40]. The gene discussed is HAVCR2; the disease is neoplasm.